Miscellaneous & Metastatic Cancer Research
EAY131: Screening for Treatment Assignment Based on Genetic Testing (Molecular Analysis for Therapy Choice [MATCH])
10231: NCORP Tissue Procurement Protocol: An NCI Cancer MoonshotSM Study
S1609: DART: Dual Anti-CTLA-4 and Anti-PD-1 blockade in Rare Tumors
CANCER CONTROL / CCDR
A221602: Olanzapine with or without fosaprepitant for the prevention of chemotherapy induced nausea and vomiting (CINV) in patients receiving highly emetogenic chemotherapy (HEC): A Phase III Randomized, Double Blind, Placebo-Controlled Trial
A221701: Phase III placebo-controlled trial to evaluate dexamethasone use for everolimus-induced oral stomatitis: prevention versus early treatment approaches
EAQ171CD: Implementing a Virtual Tobacco Treatment in Community Oncology Patients: "Smoke Free Support Study 2.0"